POST-COVID-19 CONDITION

This study offers expanded access to an infusion of human umbilical cord blood (REGENECYTE) for adults with Long COVID who are not eligible for other clinical trials. The goal is to see if this treatment can help control ongoing symptoms like chronic fatigue. Participants must ha…

This study tests whether plitidepsin, a drug previously used for cancer, can help people with long COVID. About 90 adults with moderate to severe long COVID symptoms will receive either the drug or a placebo through an IV over several weeks. Researchers will measure changes in ov…

This study tests a device called Hi-OxSR that lets people briefly rebreathe their own carbon dioxide. Early results suggest it may reduce brain fog and fatigue in people with Long COVID. The trial will enroll 120 adults to find the best dose and check safety.

This study tests whether cold water therapy (Kneipp hydrotherapy) can improve quality of life for people with Long COVID. Thirty adults with a Post-COVID diagnosis will either receive the cold water treatment or continue usual care. Researchers will measure changes in fatigue, sl…

This study tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can ease lingering COVID-19 symptoms like brain fog and fatigue. About 120 adults with long COVID will receive the treatment, and researchers will track changes in thinking speed a…

This small study tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can reduce fatigue and other symptoms in people with post-COVID condition. Researchers will enroll 40 adults who have had symptoms like chronic tiredness for at least 12 week…

This study looks at how tiny structures inside cells called mitochondria use oxygen to make energy. Researchers want to see if this process is different in people with long COVID compared to those who fully recovered. About 54 adults will wear activity trackers, answer surveys, a…